Skip to content
Governance Register

← US public companies

NEA 15 GP, LLC

SEC-identified person · CIK 1640033 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Neuehealth, Inc. NEUE Director filed 2021 - 2025
Senti Biosciences, Inc.\ SNTI Officer filed 2022 - 2025
Revolution Acceleration Acquisition Corp RAAC Officer filed 2021 - 2023
Arcellx, Inc. ACLX Officer filed 2022 - 2022
dMY Technology Group, Inc. III IONQ Officer filed 2021 - 2022
Aveo Pharmaceuticals, INC. AVEO Officer filed 2016 - 2022
Robinhood Markets, Inc. HOOD Director filed 2021 - 2022
Trine Acquisition Corp. TRNEU Officer filed 2020 - 2021
Eargo, Inc. EAR Officer filed 2020 - 2021
Reneo Pharmaceuticals, Inc. RPHM Officer filed 2021 - 2021
Inozyme Pharma, Inc. INZY Officer filed 2020 - 2020
Annexon, Inc. ANNX Officer filed 2020 - 2020
Nkarta, Inc. NKTX Officer filed 2020 - 2020
Ardelyx, INC. ARDX Officer filed 2016 - 2019
Nightstar Therapeutics plc NITE Officer filed 2019 - 2019
Tempest Therapeutics, Inc. TPST Officer filed 2018 - 2018
Oncothyreon Inc. ONTY Officer filed 2017 - 2018
Oruka Therapeutics, Inc. ORKA Officer filed 2015 - 2018
Achaogen, Inc. AKAO Officer filed 2016 - 2016

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.